company background image
ABOT logo

Abbott Laboratories (Pakistan) KASE:ABOT Stock Report

Last Price

PK₨721.96

Market Cap

PK₨70.7b

7D

-1.0%

1Y

95.2%

Updated

21 Jun, 2024

Data

Company Financials

Abbott Laboratories (Pakistan) Limited

KASE:ABOT Stock Report

Market Cap: PK₨70.7b

ABOT Stock Overview

Manufactures, imports, and markets generic pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital, and consumer products in Pakistan, Afghanistan, Sri Lanka, Bangladesh, and Switzerland.

ABOT fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance3/6
Financial Health6/6
Dividends0/6

Abbott Laboratories (Pakistan) Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Abbott Laboratories (Pakistan)
Historical stock prices
Current Share PricePK₨721.96
52 Week HighPK₨740.00
52 Week LowPK₨330.00
Beta0.67
11 Month Change4.64%
3 Month Change60.79%
1 Year Change95.20%
33 Year Change-4.05%
5 Year Change52.11%
Change since IPO1,811.36%

Recent News & Updates

Recent updates

Shareholder Returns

ABOTPK PharmaceuticalsPK Market
7D-1.0%-0.7%2.0%
1Y95.2%87.9%65.5%

Return vs Industry: ABOT exceeded the PK Pharmaceuticals industry which returned 91.3% over the past year.

Return vs Market: ABOT exceeded the PK Market which returned 64.4% over the past year.

Price Volatility

Is ABOT's price volatile compared to industry and market?
ABOT volatility
ABOT Average Weekly Movement5.0%
Pharmaceuticals Industry Average Movement5.8%
Market Average Movement5.3%
10% most volatile stocks in PK Market8.2%
10% least volatile stocks in PK Market3.2%

Stable Share Price: ABOT's share price has been volatile over the past 3 months.

Volatility Over Time: ABOT's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
18881,430n/awww.pk.abbott

Abbott Laboratories (Pakistan) Limited manufactures, imports, and markets generic pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital, and consumer products in Pakistan, Afghanistan, Sri Lanka, Bangladesh, and Switzerland. It operates through Pharmaceutical, Nutritional, Diagnostics, and Others segments. The company offers portfolio of products in various therapeutic areas, including women’s and men’s health, gastroenterology, central nervous system, pediatrics, vitamins, cardiometabolic and metabolic, pain and fever, respiratory, and hospital care.

Abbott Laboratories (Pakistan) Limited Fundamentals Summary

How do Abbott Laboratories (Pakistan)'s earnings and revenue compare to its market cap?
ABOT fundamental statistics
Market capPK₨70.68b
Earnings (TTM)PK₨2.00b
Revenue (TTM)PK₨57.70b

35.3x

P/E Ratio

1.2x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
ABOT income statement (TTM)
RevenuePK₨57.70b
Cost of RevenuePK₨44.69b
Gross ProfitPK₨13.00b
Other ExpensesPK₨11.00b
EarningsPK₨2.00b

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)20.43
Gross Margin22.54%
Net Profit Margin3.47%
Debt/Equity Ratio0%

How did ABOT perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.